IHT Wealth Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,473
Closed -$435K 1263
2025
Q4
$435K Buy
+2,473
New +$404K 0.01% 827
2025
Q2
Sell
-1,480
Closed -$203K 1153
2025
Q1
$203K Buy
+1,480
New +$212K 0.01% 1036
2024
Q3
Sell
-1,021
Closed -$237K 1147
2024
Q2
$237K Buy
+1,021
New +$222K 0.01% 884
2022
Q1
Sell
-1,111
Closed -$267K 775
2021
Q4
$267K Sell
1,111
-33
-3% -$8.48K 0.02% 652
2021
Q3
$324K Sell
1,144
-592
-34% -$194K 0.03% 567
2021
Q2
$601K Buy
1,736
+846
+95% +$256K 0.04% 465
2021
Q1
$249K Sell
890
-43
-5% -$11.6K 0.02% 693
2020
Q4
$228K Buy
933
+124
+15% +$32K 0.02% 646
2020
Q3
$229K Sell
809
-1
-0.1% -$279 0.02% 568
2020
Q2
$217K Sell
810
-55
-6% -$16.5K 0.03% 498
2020
Q1
$274K Buy
865
+16
+2% +$4.86K 0.04% 412
2019
Q4
$252K Buy
+849
New +$236K 0.03% 500
2019
Q3
Sell
-950
Closed -$222K 612
2019
Q2
$222K Buy
+950
New +$219K 0.03% 470
2018
Q2
Sell
-231
Closed -$62K 516
2018
Q1
$62K Sell
231
-25
-10% -$7.76K 0.02% 610
2017
Q4
$84K Sell
256
-18
-7% -$5.77K 0.02% 535
2017
Q3
$90K Sell
274
-18
-6% -$5.33K 0.04% 374
2017
Q2
$39 Buy
292
+48
+20% +$12.7K 0.02% 572
2017
Q1
$66K Sell
244
-85
-26% -$24K 0.04% 361
2016
Q4
$96K Buy
+329
New +$97.5K 0.07% 276

Other funds holding BIIB

IHT Wealth Management's BIIB Position: Q1 2026 in Review

IHT Wealth Management sold out of Biogen (BIIB) in Q1 2026, closing a stake of 2,473 shares — an estimated $435K sold.

IHT Wealth Management first reported a position in BIIB in Q4 2016 and held it in 19 quarters. The position peaked at $601K in Q2 2021. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • IHT Wealth Management reported no remaining Biogen position as of Q1 2026 after selling out during the quarter.
  • IHT Wealth Management sold 2,473 Biogen shares in Q1 2026, an estimated $435K.
  • IHT Wealth Management first reported a position in Biogen in Q4 2016 and held it in 19 quarters.
  • IHT Wealth Management's Biogen position peaked at $601K in Q2 2021.
  • 1,009 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on IHT Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.